| Milewski, Krzysztof |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Active, not recruiting | 3 | 17300 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
NCT06383390 / 2023-508630-34-00: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) |
|
|
| Active, not recruiting | 3 | 10000 | Europe, Canada, US, RoW | Retatrutide, LY3437943, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD) | 02/29 | 02/29 | | |
| Active, not recruiting | 2 | 150 | Europe, Canada, US | AB-1002, Gene Therapy, NAN-101 | AskBio Inc, AskBio Inc. | Adult subjects with New York Heart Association (NYHA) Class III congestive heart failure and non-ischemic cardiomyopathy | 10/26 | 12/30 | | |
NCT04777513: Evaluation of Diagnostic Accuracy, Safety, and Cost-Effectiveness of the Non-Invasive Cardiolens FFR-CT Pro Method to Measure the Fractional Flow Reserve in Diagnostics of Chronic Coronary Syndromes Versus the Standard Diagnostic Modalities. |
|
|
| Completed | N/A | 450 | Europe | CCTA (Coronary Computed Tomography Angiography), ICA (Invasive Coronary Angiography), FFR (Fractional Flow Reserve), CNBP measurement, Cardiolens FFR-CT Pro | Hemolens Diagnostics Sp. z o.o., GENELYTICA Sp. z o.o. | Stable Ischemic Heart Disease, Coronary Artery Disease | 09/22 | 05/23 | | |
| Completed | N/A | 10 | Europe, RoW | JuxtaFlow System | 3ive Labs, SCIRENT | Renal Insufficiency, Acute Kidney Injury | 12/23 | 01/24 | | |
| Completed | N/A | 309 | Europe, RoW | CTO PCI using DCB-only strategy | National Institute of Cardiology, Warsaw, Poland | Coronary Artery Disease, Total Occlusion of Coronary Artery | 12/24 | 01/25 | | |
MILESTONE, NCT01311323: Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease |
|
|
| Recruiting | N/A | 1000 | Europe | PCI, •Percutaneous coronary intervention, •Multivessel coronary disease, •Left main narrowing, CABG, Multivessel coronary artery disease, Coronary artery bypass graft, Left Main narrowing | American Heart of Poland, Andrzej Frycz Modrzewski Krakow University | Multivessel Coronary Artery Disease, Acute Coronary Syndrome | 12/28 | 11/30 | | |
| Recruiting | N/A | 300 | Europe | Pacemaker implantation, Cardioneuroablation (CNA) | American Heart of Poland | Atrioventricular Block | 08/26 | 12/26 | | |
CLEARANCE, NCT04298723: Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding. |
|
|
| Recruiting | N/A | 530 | Europe | Percutaneous closure of the LAA (Watchman / Watchman FLX) | Jena University Hospital, KCRI | Intracranial Hemorrhages, Atrial Fibrillation (AF), Atrial Flutter | 06/29 | 12/29 | | |
| Recruiting | N/A | 4000 | Europe, Canada, US | WATCHMAN device | Hamilton Health Sciences Corporation, McMaster University, Population Health Research Institute, Boston Scientific Corporation | Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism | 09/29 | 12/29 | | |
| Okniński, Antoni |
NCT06289790: Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS) |
|
|
| Completed | N/A | 61 | Europe | Erector Spinae Plane (ESP) block, ESP blockade, Lignocaine, Lignocaine infusion, Bupivacaine | Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland | Thoracic Surgery, Video-Assisted | 10/25 | 10/25 | | |
